Bryan Davis, PsyD, MS: Behavioral Health and CMNI in Treating MS
June 11th 2020The clinical health psychology fellow at the Mellen Center for MS Treatment and Research at Cleveland Clinic details the use of behavioral health and potential use of Conformity to Masculine Norms Inventory (CMNI) tool in multiple sclerosis care.
Jessica Ailani, MD: The Ongoing Expansion in Headache Medicine
June 11th 2020The AHS fellow, director of MedStar Georgetown Headache Center, and associate professor of neurology at MedStar Georgetown University Hospital spoke to the rapid expansion of headache medicine and what new research will be discussed at AHS 2020.
Jessica Ailani, MD: What to Expect From the American Headache Society Meeting
June 8th 2020The AHS fellow, director of MedStar Georgetown Headache Center, and associate professor of neurology at MedStar Georgetown University Hospital spoke to what to expect from this year’s annual scientific meeting.
Bryan Davis, PsyD, MS: Exploring Masculinity Norms in MS
June 6th 2020The clinical healthy psychology fellow at the Mellen Center for MS Treatment and Research at Cleveland Clinic discussed the reasoning behind his study evaluating conformity of masculine norms in patients with multiple sclerosis.
James Wheless, MD: Consequences of Virtual Societal Meetings
June 4th 2020The chief of pediatric neurology at the University of Tennessee Health Science Center, and director of the Comprehensive Epilepsy Program at Le Bonheur Children's Hospital spoke to the difficulty in connecting with colleagues with virtual meetings.
Jerrold L. Vitek, MD, PhD: Multiple Independent Contact Current-Controlled DBS Technology
June 1st 2020The professor and head of the department of neurology at the University of Minnesota discussed what multiple independent contact current-controlled devices offer physicians conducting deep brain stimulation.
CMSC 2020 Day 3: Laura Safar, MD on Use of Psychotropics in MS
May 29th 2020Laura Safar, MD, presents her lecture titled, "Use of Psychotropics in MS: Antidepressants, Anti-anxiety Agents, Mood Stabilizers, Hypnotics, Antipsychotics, and Cognitive Enhancers" as part of the 2020 CMSC Virtual Annual Meeting.